News
News Center
2021-06-21
Understand in One Article: The Mechanism Behind Mesenchymal Stem Cell Therapy for COPD
Life depends on a single breath—but once you develop COPD, taking a deep, effortless inhale becomes harder than reaching for the stars. Imagine being buried alive, with dirt already pressing against your throat; or picture yourself climbing a mountain, only to feel as though something—a lump of blood, perhaps—has lodged painfully in your throat. These are the very real experiences faced by COPD patients every day.
+
2021-06-15
The implementation plan clearly states: "Support the growth of the precision medicine industry. Strengthen technological development in the field of genetic testing and take the lead in pioneering clinical trials involving stem cells. Encourage enterprises to advance genetic testing technologies, promoting their application in areas such as disease screening and COVID-19 nucleic acid testing. Additionally, support the establishment of a national-local joint engineering laboratory dedicated to personalized cell therapy technologies, driving the standardization of technical and management protocols within the cell industry. Finally, facilitate research and translational applications of cutting-edge technologies—including stem cell, immune cell, and gene therapies—within medical and research institutions located in the free trade zone." (Responsible Units: District Health Commission, District Science and Technology Innovation Bureau, District Industry and Information Technology Bureau)
+![[State Council] Will prioritize supporting regulatory science research in areas such as cell-based therapies, accelerating the development and launch of new products.](https://omo-oss-image.thefastimg.com/portal-saas/pg2024091209142318355/cms/image/23227838-4670-4335-bf7a-d0906f1dae6c.jpg "[State Council] Will prioritize supporting regulatory science research in areas such as cell-based therapies, accelerating the development and launch of new products.")
2021-05-27
The opinion clearly states: prioritize support for regulatory science research in areas such as traditional Chinese medicine, biologics (including vaccines), gene therapies, cell-based therapies, AI-powered medical devices, new materials for medical devices, and novel cosmetic ingredients, thereby accelerating the development and market launch of innovative products.
+
2021-05-25
CCTV: Stem cells help a cerebral palsy patient take their first steps in over 20 years.
The development of stem cell technology has become increasingly mature, demonstrating remarkable therapeutic efficacy in the diagnosis and treatment of many challenging and complex diseases, and offering new hope for patients suffering from these often-intractable conditions.
+
2021-05-17
On May 12, the 84th National Pharmaceutical Fair (hereinafter referred to as "PharmFair") kicked off with great fanfare at the Shanghai National Exhibition and Convention Center. Renowned as a "Time-Honored Chinese Brand" with a rich history spanning 371 years and listed on the "Intangible Cultural Heritage Protection Catalog," Jiuzhitang Group showcased its comprehensive lineup at this year's event, featuring prescription drugs, OTC products, innovative health solutions, cutting-edge stem-cell initiatives, and its thriving internet-based healthcare platform.
+![[Invitation] Jiuzhitang Group cordially invites you to visit our booth 82J18 at the 84th National Pharmaceutical Fair.](https://omo-oss-image.thefastimg.com/portal-saas/pg2024091209142318355/cms/image/0fd7b347-e980-4db4-aee6-5337e58a38e5.png "[Invitation] Jiuzhitang Group cordially invites you to visit our booth 82J18 at the 84th National Pharmaceutical Fair.")
2021-04-29
[Invitation] Jiuzhitang Group cordially invites you to visit the 84th National Pharmaceutical Fair, where we’ll be showcasing at Booth 82J18 in Hall 8.2.
+
2021-04-28
Does the more stem cells used, the better the treatment effect?
In fact, there are many factors that influence the effectiveness of cell therapies—so we shouldn’t focus solely on dosage, but rather pay closer attention to cell quality and whether clinical application is being carried out correctly.
+
2021-04-20
The key document explicitly states: "Carry out the initial review of clinical research institutions and projects involving stem cells and somatic cells, strengthen policy advisory services and pre-application guidance, support collaborative efforts between registered institutions and companies in conducting clinical research, and provide crucial evidence-based support to accelerate the transition of stem cell therapies into clinical practice."
+
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy